Rogier Jongen

Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice

Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection

Turning Tumors into Vaccines: Co-opting the Innate Immune System

Oncology Meets Immunology: The Cancer-Immunity Cycle

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Vaccines for established cancer: overcoming the challenges posed by immune evasion

Immunogenic cell death in cancer and infectious disease

Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses

Targeting apoptosis in cancer therapy

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Dendritic-Cell-Based Therapeutic Cancer Vaccines

Cancer-related inflammation and treatment effectiveness

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer

Putting p53 in Context

A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer

Addition of interferon‐α to the p53‐SLP® vaccine results in increased production of interferon‐γ in vaccinated colorectal cancer patients: A phase I/II clinical trial